P. McCloud

发表

A Phase 3 Randomized, Controlled Trial of Astodrimer 1% Gel for Preventing Recurrent Bacterial Vaginosis

K. Agnew, J. Schwebke, J. Paull, 2020, medRxiv.

Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis.

J. Schwebke, K. Peters, J. Paull, 2019, European journal of obstetrics, gynecology, and reproductive biology.

Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial

Graham P. Heery, J. Paull, G. Kinghorn, 2022, Scientific reports.

A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis European Journal of Obstetrics & Gynecology and Reproductive Biology: X

K. Agnew, J. Paull, G. Kinghorn, 2021 .

Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine

A. Cunningham, D. Dwyer, R. Booy, 2020, Human vaccines & immunotherapeutics.

Longitudinal study of clinical prognostic factors in patients with early rheumatoid arthritis: the PREDICT study

G. Littlejohn, J. Jager, P. Bird, 2017, International journal of rheumatic diseases.

Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial

J. Paull, G. Kinghorn, C. Luscombe, 2022, Scientific reports.

Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial

J. Plummer, D. Currow, C. McDonald, 2019, Thorax.

A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study protocol

Miriam J. Johnson, L. Denehy, J. Miners, 2017, BMJ Open.

A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis

J. Schwebke, J. Paull, G. Kinghorn, 2020, PloS one.

Controlled-release oxycodone versus placebo in the treatment of chronic breathlessness - a multi-site randomised placebo controlled trial.

D. Currow, C. McDonald, M. Ekström, 2020, Journal of pain and symptom management.

A review of the treatment options for skin rash induced by EGFR-targeted therapies: Evidence from randomized clinical trials and a meta-analysis

R. Hofheinz, S. Heeger, J. Ocvirk, 2013, Radiology and oncology.

A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis

K. Agnew, J. Schwebke, J. Paull, 2020, medRxiv.

Prescribed Water Intake in Autosomal Dominant Polycystic Kidney Disease

David W. Johnson, Marie E. Edwards, Adriana V. Gregory, 2021, NEJM Evidence.

Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)

David W. Johnson, Marie E. Edwards, B. Erickson, 2018, BMJ Open.

PrescribedWater Intake in Autosomal Dominant Polycystic Kidney Disease

David W. Johnson, Marie E. Edwards, Adriana V. Gregory, 2021 .

Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)

David W. Johnson, Marie E. Edwards, B. Erickson, 2018, BMJ Open.

Regular extended release morphine for chronic breathlessness: a multi-centre double-blind RCT

A. Abernethy, J. Plummer, D. Currow, 2018, Rehabilitation and Chronic Care.